The WACC of Summit Therapeutics Inc (SMMT) is 9.9%.
| Range | Selected | |
| Cost of equity | 8.20% - 11.70% | 9.95% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 8.2% - 11.6% | 9.9% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.94 | 1.21 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 8.20% | 11.70% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0.01 | 0.01 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 8.2% | 11.6% |
| Selected WACC | 9.9% | |